3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Genitourinary
1
Gastrointestinal
1
CNS
1
Conditions
Pancreatic Neoplasms
6
Stomach Neoplasms
3
Esophageal Neoplasms
3
Colorectal Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Breast Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
2
Rectal Neoplasms
2
Neoplasms, Germ Cell and Embryonal
2
Multiple Myeloma
2
Liver Neoplasms
2
Hepatoblastoma
2
Colonic Neoplasms
2
Carcinoma, Hepatocellular
2
Anus Neoplasms
2
Wilms Tumor
1
Vulvar Neoplasms
1
Uterine Cervical Neoplasms
1
Thrombocytosis
1
Sarcoma, Ewing
1
Salivary Gland Neoplasms
1
Rhabdomyosarcoma
1
Prostatic Neoplasms
1
Primary Myelofibrosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Penile Neoplasms
1
Ototoxicity
1
Neuroblastoma
1
Neoplasms, Squamous Cell
1
Neoplasm Metastasis
1
Interventions
X-Rays
6
Magnetic Resonance Spectroscopy
6
Specimen Handling
5
Phantoms, Imaging
5
Nuclear Medicine Department, Hospital
4
Melphalan
4
fludarabine
3
Granulocyte Colony-Stimulating Factor
3
Cyclophosphamide
3
Busulfan
3
Biopsy
3
ulixertinib
2
tipifarnib
2
tazemetostat
2
selpercatinib
2
palbociclib
2
olaparib
2
larotrectinib
2
ivosidenib
2
ensartinib
2
Vemurafenib
2
Trabectedin
2
Thiotepa
2
Temozolomide
2
Sirolimus
2
Mesna
2
LY3023414
2
Cytoreduction Surgical Procedures
2
Cisplatin
2
talazoparib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Rhabdomyosarcoma
×
Vorinostat
×
Gastrointestinal
×
Clear all
NCT04308330
2026-04-15
NYMC195
New York Medical College
Phase 1
Recruiting
30 enrolled